tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jonathan Miller, 2 are a HOLD (33.33%), 4 are a BUY (66.67%).
Analyst Jonathan Miller, currently employed at EVERCORE, carries an average stock price target met ratio of 16.67% that have a potential upside of 1.21% achieved within 17 days. Previously, Jonathan Miller worked at LAKE STREET.
Jonathan Miller’s has documented 12 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARVN, Arvinas at 10-Aug-2026.
Analyst best performing recommendations are on NTLA (INTELLIA THERAPEUTICS).
The best stock recommendation documented was for NTLA (INTELLIA THERAPEUTICS) at 3/2/2026. The price target of $16 was fulfilled within 51 days with a profit of $0.56 (3.63%) receiving and performance score of 0.71.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Feb-2026
$17
$12.46 (274.45%)
$20
4 months 23 days ago
(08-Jun-2026)
0/2 (0%)
$10.74 (171.57%)
Buy Since 03-Apr-2023
$20
5 months 23 days ago
(08-May-2026)
4/14 (28.57%)
$8.96 (81.16%)
126
Buy Since 26-Aug-2024
$23
$15.26 (197.16%)
$30
6 months 25 days ago
(06-Apr-2026)
0/4 (0%)
$9.12 (65.71%)
Buy Since 25-Apr-2023
$17
$12.46 (274.45%)
$20
1 years 2 months 24 days ago
(07-Aug-2025)
1/6 (16.67%)
$11.7 (220.75%)
371
Buy Since 04-Jan-2024
$30
$25.46 (560.79%)
$22
1 years 7 months 7 days ago
(24-Mar-2025)
0/2 (0%)
$19.2 (177.78%)
Which stock is Jonathan Miller most bullish on?
Which stock is Jonathan Miller most reserved on?
What Year was the first public recommendation made by Jonathan Miller?
